Stress and Symptom Burden in Oncology Patients During the COVID-19 Pandemic.


Journal

Journal of pain and symptom management
ISSN: 1873-6513
Titre abrégé: J Pain Symptom Manage
Pays: United States
ID NLM: 8605836

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 30 07 2020
revised: 24 08 2020
accepted: 28 08 2020
pubmed: 6 9 2020
medline: 11 11 2020
entrez: 5 9 2020
Statut: ppublish

Résumé

No information is available on oncology patients' level of stress and symptom burden during the coronavirus disease 2019 (COVID-19) pandemic. To evaluate for differences in demographic and clinical characteristics, levels of social isolation and loneliness, and the occurrence and severity of common symptoms between oncology patients with low vs. high levels of COVID-19 and cancer-related stress. In addition, to determine which of these characteristics were associated with membership in the high-stressed group. Patients were 18 years and older; had a diagnosis of cancer; and were able to complete an online survey. Of the 187 patients in this study, 31.6% were categorized in the stressed group (Impact of Event Scale-Revised [score of ≥24]). Stressed group's Impact of Event Scale-Revised score exceeds previous benchmarks in oncology patients and equates with probable post-traumatic stress disorder. In this stressed group, patients reported occurrence rates for depression (71.2%), anxiety (78.0%), sleep disturbance (78.0%), evening fatigue (55.9%), cognitive impairment (91.5%), and pain (75.9%). Symptom severity scores equate with clinically meaningful levels for each symptom. We identified alarmingly high rates of stress and an extraordinarily high symptom burden among patients with cancer, exceeding those previously benchmarked in this population and on par with noncancer patients with post-traumatic stress disorder. Given that the COVID-19 pandemic will likely impact cancer care for an indefinite period, clinicians must exhibit increased vigilance in their assessments of patients' level of stress and symptom burden. Moreover, an increase in referrals to appropriate supportive care resources must be prioritized for high-risk patients.

Identifiants

pubmed: 32889039
pii: S0885-3924(20)30724-7
doi: 10.1016/j.jpainsymman.2020.08.037
pmc: PMC7462969
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e25-e34

Subventions

Organisme : NCI NIH HHS
ID : K07 CA197077
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.

Références

Global Health. 2020 Jul 6;16(1):57
pubmed: 32631403
Support Care Cancer. 2020 Oct;28(10):4697-4706
pubmed: 31956947
J Pain Symptom Manage. 2017 May;53(5):887-900.e2
pubmed: 28063861
J Pers Assess. 1978 Jun;42(3):290-4
pubmed: 660402
J Palliat Med. 2020 Sep;23(9):1191-1197
pubmed: 32228350
Am J Geriatr Psychiatry. 2020 Sep;28(9):993-998
pubmed: 32576424
Public Health. 2017 Nov;152:157-171
pubmed: 28915435
Arthritis Rheum. 2003 Apr 15;49(2):156-63
pubmed: 12687505
J Pers Soc Psychol. 1980 Sep;39(3):472-80
pubmed: 7431205
J Pain Symptom Manage. 2018 Jul;56(1):88-97
pubmed: 29524582
Oncologist. 2020 Jun;25(6):e936-e945
pubmed: 32243668
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Patient Educ Couns. 2004 Feb;52(2):131-41
pubmed: 15132517
Int J Environ Res Public Health. 2020 Jun 08;17(11):
pubmed: 32521776
Support Care Cancer. 2016 Jan;24(1):481-497
pubmed: 26416490
Nat Sci Sleep. 2018 Jul 17;10:193-201
pubmed: 30046255
Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):5797-801
pubmed: 23530191
J Nerv Ment Dis. 2002 Mar;190(3):175-82
pubmed: 11923652
Lancet. 2020 Jun 20;395(10241):1919-1926
pubmed: 32473682
Brain Behav Immun. 2020 Jul;87:84-92
pubmed: 32335200
Sleep. 1992 Dec;15(6):493-8
pubmed: 1475563
Psychiatry Res. 1991 Mar;36(3):291-8
pubmed: 2062970
Clin Breast Cancer. 2020 Oct;20(5):e651-e662
pubmed: 32709505
Lancet. 2020 Jun 20;395(10241):1907-1918
pubmed: 32473681
QJM. 2020 Jun 22;:
pubmed: 32569360
J Affect Disord. 2012 Dec 10;141(2-3):343-51
pubmed: 22727334
Behav Res Ther. 2003 Dec;41(12):1489-96
pubmed: 14705607
Lancet Psychiatry. 2017 Apr;4(4):330-338
pubmed: 28109647
Biol Res Nurs. 2004 Apr;5(4):311-8
pubmed: 15068660
Transl Psychiatry. 2020 Jul 31;10(1):263
pubmed: 32737292
Psychooncology. 2011 Feb;20(2):194-202
pubmed: 20213858
Clin Infect Dis. 2021 Jan 27;72(2):340-350
pubmed: 33501974
J Clin Oncol. 2007 Oct 10;25(29):4526-7
pubmed: 17846452
Cancer. 2017 Feb 1;123(3):476-484
pubmed: 27716900
J Pain Symptom Manage. 2020 Mar;59(3):646-657
pubmed: 31711968
Radiother Oncol. 2020 Aug;149:109-110
pubmed: 32342866
Psychol Assess. 2017 Mar;29(3):320-328
pubmed: 27280744
J Pain Symptom Manage. 2019 Mar;57(3):646-660.e1
pubmed: 30550833
Psychoneuroendocrinology. 2016 Sep;71:127-35
pubmed: 27262345
Nat Med. 2020 May;26(5):665-671
pubmed: 32405058
Psychosomatics. 2009 Jul-Aug;50(4):383-91
pubmed: 19687179
Depress Anxiety. 2020 Aug;37(8):706-714
pubmed: 32627255
J Pers Assess. 1996 Feb;66(1):20-40
pubmed: 8576833
Neurosci Biobehav Rev. 2020 May;112:519-541
pubmed: 32092313
Neurosci Biobehav Rev. 2020 Oct;117:65-77
pubmed: 31491473
PLoS One. 2013 Dec 31;8(12):e83916
pubmed: 24391844
Gerontologist. 2020 Sep 15;60(7):e491-e501
pubmed: 31201744
Curr Psychiatry Rep. 2019 Feb 7;21(2):8
pubmed: 30729328
Support Care Cancer. 2018 Feb;26(2):405-414
pubmed: 29058128
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
Cytokine. 2017 Mar;91:187-210
pubmed: 28110208
J Clin Psychol. 1988 Mar;44(2):203-6
pubmed: 3360935
Psychooncology. 2020 Apr;29(4):604-616
pubmed: 31834657
Pain. 1983 Oct;17(2):197-210
pubmed: 6646795
Can Fam Physician. 2020 Mar;66(3):176-182
pubmed: 32165464
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789
Int J Mol Sci. 2019 Jun 06;20(11):
pubmed: 31174326
Cancer Nurs. 2020 Sep/Oct;43(5):402-410
pubmed: 30998605
J Pain. 2015 Feb;16(2):186-96
pubmed: 25433166
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Ann Acad Med Singap. 2020 Jan;49(3):155-160
pubmed: 32200399
J Behav Med. 2018 Apr;41(2):243-252
pubmed: 28983735
Int J Soc Psychiatry. 2020 Sep;66(6):525-527
pubmed: 32349580
Curr Treat Options Oncol. 2020 Feb 5;21(2):17
pubmed: 32025928
Brain Behav Immun. 2020 Jul;87:100-106
pubmed: 32353518
Disaster Med Public Health Prep. 2020 Dec 22;:1-7
pubmed: 33706845
J Evid Based Complementary Altern Med. 2017 Jul;22(3):502-512
pubmed: 30208733
Front Oncol. 2020 Jul 10;10:1270
pubmed: 32754447
Depress Anxiety. 2003;18(2):76-82
pubmed: 12964174
Brain Behav Immun. 2020 Jul;87:40-48
pubmed: 32298802
Psychiatry Res. 2013 Feb 28;205(3):241-6
pubmed: 22985544
Pain. 2005 Jan;113(1-2):37-44
pubmed: 15621362
Brain Behav Immun. 2020 Aug;88:559-565
pubmed: 32330593
Int Rev Psychiatry. 2014 Feb;26(1):102-13
pubmed: 24716504

Auteurs

Christine Miaskowski (C)

School of Nursing, University of California, San Francisco, California, USA. Electronic address: chris.miaskowski@ucsf.edu.

Steven M Paul (SM)

School of Nursing, University of California, San Francisco, California, USA.

Karin Snowberg (K)

School of Nursing, University of California, San Francisco, California, USA.

Maura Abbott (M)

Columbia University Medical Center, New York, New York, USA.

Hala Borno (H)

School of Medicine, University of California, San Francisco, California, USA.

Susan Chang (S)

School of Medicine, University of California, San Francisco, California, USA.

Lee M Chen (LM)

School of Medicine, University of California, San Francisco, California, USA.

Bevin Cohen (B)

Mount Sinai Medical Center, New York, New York, USA.

Marilyn J Hammer (MJ)

Dana Farber Cancer Institute, Boston, Massachusetts, USA.

Stacey A Kenfield (SA)

School of Medicine, University of California, San Francisco, California, USA.

Kord M Kober (KM)

School of Nursing, University of California, San Francisco, California, USA.

Jon D Levine (JD)

School of Medicine, University of California, San Francisco, California, USA.

Rachel Pozzar (R)

Dana Farber Cancer Institute, Boston, Massachusetts, USA.

Kim F Rhoads (KF)

School of Medicine, University of California, San Francisco, California, USA.

Erin L Van Blarigan (EL)

School of Medicine, University of California, San Francisco, California, USA.

Katherine Van Loon (K)

School of Medicine, University of California, San Francisco, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH